We are live on ! Find out more
GMAB icon

Genmab
GMAB

133 hedge funds and large institutions have $564M invested in Genmab in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 13

52% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 27

37% more funds holding

Funds holding: 97 → 133 (+36)

11% more capital invested

Capital invested by funds: $511M → $564M (+$53.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.36% less ownership

Funds ownership: 38.78% → 36.42% (-2.4%)

Holders
133
Holders Change
+36
Holders Change %
+37.11%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
50
Increased
41
Reduced
27
Closed
13
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.55M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.33M
3
Bank of America
Bank of America
North Carolina
+$4.29M
4
CS
Candriam SCA
Luxembourg
+$4.2M
5
FAM
Fred Alger Management
New York
+$4.08M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$15.6M
2
HM
HealthCor Management
New York
-$14.1M
3
TIP
Torray Investment Partners
Maryland
-$11.8M
4
RG
Redmile Group
California
-$6.81M
5
SIG
Senator Investment Group
New York
-$6.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
CPC
51
Cookson Peirce & Co
Pennsylvania
$709K +$693K +31,765 New
NA
52
Navellier & Associates
Nevada
$646K +$632K +28,938 New
WAM
53
Wealthspire Advisors (Maryland)
Maryland
$622K -$10.7K -488 -2%
AI
54
Atria Investments
North Carolina
$560K +$547K +25,065 New
CSS
55
Cubist Systematic Strategies
Connecticut
$537K +$525K +24,058 New
KWMG
56
King Wealth Management Group
Florida
$489K -$109K -5,000 -19%
RFC
57
Regions Financial Corp
Alabama
$443K +$433K +19,833 New
Geode Capital Management
58
Geode Capital Management
Massachusetts
$395K -$67.6K -3,099 -15%
TCM
59
Tekla Capital Management
Massachusetts
$369K +$361K +16,520 New
LA
60
LVW Advisors
New York
$353K +$129K +5,920 +60%
CI
61
Cavalier Investments
Georgia
$337K +$330K +15,100 New
Ohio Public Employees Retirement System (OPERS)
62
Ohio Public Employees Retirement System (OPERS)
Ohio
$330K +$323K +14,800 New
Citigroup
63
Citigroup
New York
$320K +$260K +11,915 +480%
VAS
64
Vestmark Advisory Solutions
Massachusetts
$311K +$15.2K +698 +5%
QCG
65
Quadrant Capital Group
Ohio
$296K +$31.3K +1,434 +12%
HSA
66
HBK Sorce Advisory
Pennsylvania
$292K -$131 -6 -0%
HSBC Holdings
67
HSBC Holdings
United Kingdom
$286K -$28.4K -1,300 -9%
TD Asset Management
68
TD Asset Management
Ontario, Canada
$284K -$2.71K -124 -0.7%
ATC
69
Argent Trust Co
Tennessee
$257K +$5.15K +236 +2%
MSAM
70
Moloney Securities Asset Management
Missouri
$251K -$10.9K -500 -4%
PNC Financial Services Group
71
PNC Financial Services Group
Pennsylvania
$245K +$17.7K +810 +8%
Truist Financial
72
Truist Financial
North Carolina
$237K +$232K +10,626 New
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
$233K +$227K +10,417 New
M&T Bank
74
M&T Bank
New York
$233K +$228K +10,435 New
LNWWM
75
Laird Norton Wetherby Wealth Management
California
$225K +$220K +10,092 New
1 2
3
4 5

GMAB Hedge Fund Activity: Q4 2019 in Review

133 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q4 2019, worth a combined $564M — up 11% from $511M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new GMAB positions and 13 closed out — a net gain of 37 holders — while 41 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $7.55M. The largest seller was Citadel Advisors, cutting an estimated $15.6M.

  • 133 institutional investors held Genmab (GMAB) as of Q4 2019, up from 97 in Q3 2019.
  • Funds reported $564M of Genmab stock for Q4 2019, up 11% quarter-over-quarter.
  • 50 funds opened new Genmab positions in Q4 2019 and 13 closed out, a net change of +37 holders.
  • The largest Genmab buyer in Q4 2019 was BlackRock, an estimated $7.55M added.
  • The largest Genmab seller in Q4 2019 was Citadel Advisors, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2019.